Orthofix Medical Ownership
| OFIX Stock | USD 14.62 0.27 1.81% |
Shares in Circulation | First Issued 1991-03-31 | Previous Quarter 37.3 M | Current Value 37.7 M | Avarage Shares Outstanding 16.7 M | Quarterly Volatility 5.1 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Orthofix |
Orthofix Stock Ownership Analysis
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.83. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthofix Medical has Price/Earnings To Growth (PEG) ratio of 0.33. The entity recorded a loss per share of 3.36. The firm had not issued any dividends in recent years. Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Orthofix Intl operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1087 people. To find out more about Orthofix Medical contact Massimo Calafiore at 214 937 2000 or learn more at https://www.orthofix.com.Besides selling stocks to institutional investors, Orthofix Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Orthofix Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Orthofix Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Orthofix Medical Quarterly Liabilities And Stockholders Equity |
|
Orthofix Medical Insider Trades History
About 4.0% of Orthofix Medical are currently held by insiders. Unlike Orthofix Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Orthofix Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Orthofix Medical's insider trades
Orthofix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Orthofix Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orthofix Medical backward and forwards among themselves. Orthofix Medical's institutional investor refers to the entity that pools money to purchase Orthofix Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Emerald Advisers, Llc | 2024-03-31 | 765.2 K | Awm Investment Company Inc | 2023-12-31 | 474.5 K | Millennium Management Llc | 2024-03-31 | 433.7 K | Emerald Mutual Fund Advisers Trust | 2024-03-31 | 394.7 K | Tejara Capital Ltd | 2023-12-31 | 394.1 K | Jacobs Levy Equity Management, Inc. | 2024-03-31 | 391.3 K | Northern Trust Corp | 2023-12-31 | 355.1 K | Dimensional Fund Advisors, Inc. | 2024-03-31 | 342.6 K | Renaissance Technologies Corp | 2023-12-31 | 339.3 K | Rubric Capital Management Lp | 2023-12-31 | 3.7 M | Armistice Capital, Llc | 2023-12-31 | 3.6 M |
Orthofix Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthofix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthofix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthofix Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cedron Jorge Andres over a month ago Acquisition by Cedron Jorge Andres of 28648 shares of Orthofix Medical at 13.09 subject to Rule 16b-3 | ||
Cedron Jorge Andres over a month ago Insider Trading | ||
Gillespie Geoffrey C over two months ago Disposition of 10967 shares by Gillespie Geoffrey C of Orthofix Medical at 13.29 subject to Rule 16b-3 | ||
Jon Serbousek over a year ago Payment of 6141 shares by Jon Serbousek of Orthofix Medical subject to Rule 16b-3 | ||
Valentine Keith over a year ago Payment of 16290 shares by Valentine Keith of Orthofix Medical subject to Rule 16b-3 | ||
Jon Serbousek over a year ago Payment of 5142 shares by Jon Serbousek of Orthofix Medical subject to Rule 16b-3 | ||
Valentine Keith over a year ago Payment of 5824 shares by Valentine Keith of Orthofix Medical subject to Rule 16b-3 |
Orthofix Medical Corporate Filings
8K | 7th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 29th of April 2024 Other Reports | ViewVerify | |
F3 | 17th of April 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 16th of April 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Orthofix Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Orthofix Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Orthofix Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Orthofix Medical Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orthofix Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Orthofix Stock analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Orthofix Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orthofix Medical. If investors know Orthofix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orthofix Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.36) | Revenue Per Share 20.414 | Quarterly Revenue Growth 0.077 | Return On Assets (0.03) | Return On Equity (0.20) |
The market value of Orthofix Medical is measured differently than its book value, which is the value of Orthofix that is recorded on the company's balance sheet. Investors also form their own opinion of Orthofix Medical's value that differs from its market value or its book value, called intrinsic value, which is Orthofix Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orthofix Medical's market value can be influenced by many factors that don't directly affect Orthofix Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orthofix Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orthofix Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orthofix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.